Lawrence M. Blatt 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:30 pm Purchase | 2026-03-31 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Lawrence M. Blatt | 286,213 5.100% | 110,704 (+63.08%) | Filing |
| 2025-03-12 8:30 pm Purchase | 2025-03-10 | 13D | ALIGOS THERAPEUTICS INC NE ALGS | Lawrence M. Blatt | 175,509 3.200% | 19,979 (+12.85%) | Filing |